[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Transdermal Skin Patches-Global Market Status and Trend Report 2013-2023

February 2018 | 152 pages | ID: T3B38CD00BDEN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Transdermal Skin Patches-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Transdermal Skin Patches industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Transdermal Skin Patches 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Transdermal Skin Patches worldwide, with company and product introduction, position in the Transdermal Skin Patches market
Market status and development trend of Transdermal Skin Patches by types and applications
Cost and profit status of Transdermal Skin Patches, and marketing status
Market growth drivers and challenges

The report segments the global Transdermal Skin Patches market as:

Global Transdermal Skin Patches Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America
Europe
China
Japan
Rest APAC
Latin America

Global Transdermal Skin Patches Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Drug in Adhesive
Matrix
Reservoir
Vapor
Other

Global Transdermal Skin Patches Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Transdermal Skin Patches Market: Manufacturers Segment Analysis (Company and Product introduction, Transdermal Skin Patches Sales Volume, Revenue, Price and Gross Margin):

Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Luye Pharma Group
Hisamitsu Pharmaceutical
Mundipharma International
Purdue Pharma

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF TRANSDERMAL SKIN PATCHES

1.1 Definition of Transdermal Skin Patches in This Report
1.2 Commercial Types of Transdermal Skin Patches
  1.2.1 Drug in Adhesive
  1.2.2 Matrix
  1.2.3 Reservoir
  1.2.4 Vapor
  1.2.5 Other
1.3 Downstream Application of Transdermal Skin Patches
  1.3.1 Hospital Pharmacies
  1.3.2 Retail Pharmacies
  1.3.3 Online Pharmacies
1.4 Development History of Transdermal Skin Patches
1.5 Market Status and Trend of Transdermal Skin Patches 2013-2023
  1.5.1 Global Transdermal Skin Patches Market Status and Trend 2013-2023
  1.5.2 Regional Transdermal Skin Patches Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Transdermal Skin Patches 2013-2017
2.2 Production Market of Transdermal Skin Patches by Regions
  2.2.1 Production Volume of Transdermal Skin Patches by Regions
  2.2.2 Production Value of Transdermal Skin Patches by Regions
2.3 Demand Market of Transdermal Skin Patches by Regions
2.4 Production and Demand Status of Transdermal Skin Patches by Regions
  2.4.1 Production and Demand Status of Transdermal Skin Patches by Regions 2013-2017
  2.4.2 Import and Export Status of Transdermal Skin Patches by Regions 2013-2017

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Production Volume of Transdermal Skin Patches by Types
3.2 Production Value of Transdermal Skin Patches by Types
3.3 Market Forecast of Transdermal Skin Patches by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Transdermal Skin Patches by Downstream Industry
4.2 Market Forecast of Transdermal Skin Patches by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TRANSDERMAL SKIN PATCHES

5.1 Global Economy Situation and Trend Overview
5.2 Transdermal Skin Patches Downstream Industry Situation and Trend Overview

CHAPTER 6 TRANSDERMAL SKIN PATCHES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

6.1 Production Volume of Transdermal Skin Patches by Major Manufacturers
6.2 Production Value of Transdermal Skin Patches by Major Manufacturers
6.3 Basic Information of Transdermal Skin Patches by Major Manufacturers
  6.3.1 Headquarters Location and Established Time of Transdermal Skin Patches Major Manufacturer
  6.3.2 Employees and Revenue Level of Transdermal Skin Patches Major Manufacturer
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 TRANSDERMAL SKIN PATCHES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Johnson & Johnson
  7.1.1 Company profile
  7.1.2 Representative Transdermal Skin Patches Product
  7.1.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.2 Novartis AG
  7.2.1 Company profile
  7.2.2 Representative Transdermal Skin Patches Product
  7.2.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Novartis AG
7.3 Mylan N.V.
  7.3.1 Company profile
  7.3.2 Representative Transdermal Skin Patches Product
  7.3.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Mylan N.V.
7.4 Teva Pharmaceutical Industries
  7.4.1 Company profile
  7.4.2 Representative Transdermal Skin Patches Product
  7.4.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
7.5 Luye Pharma Group
  7.5.1 Company profile
  7.5.2 Representative Transdermal Skin Patches Product
  7.5.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Luye Pharma Group
7.6 Hisamitsu Pharmaceutical
  7.6.1 Company profile
  7.6.2 Representative Transdermal Skin Patches Product
  7.6.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
7.7 Mundipharma International
  7.7.1 Company profile
  7.7.2 Representative Transdermal Skin Patches Product
  7.7.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Mundipharma International
7.8 Purdue Pharma
  7.8.1 Company profile
  7.8.2 Representative Transdermal Skin Patches Product
  7.8.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Purdue Pharma

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TRANSDERMAL SKIN PATCHES

8.1 Industry Chain of Transdermal Skin Patches
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TRANSDERMAL SKIN PATCHES

9.1 Cost Structure Analysis of Transdermal Skin Patches
9.2 Raw Materials Cost Analysis of Transdermal Skin Patches
9.3 Labor Cost Analysis of Transdermal Skin Patches
9.4 Manufacturing Expenses Analysis of Transdermal Skin Patches

CHAPTER 10 MARKETING STATUS ANALYSIS OF TRANSDERMAL SKIN PATCHES

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications